Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.
Helia Group announces the departure of CEO Pauline Blight-Johnston after five years, appointing CFO Michael Cant as interim CEO amid evolving market conditions. The leadership change signals a strategic pivot for the lender mortgage insurer.
The ACCC has decided not to oppose Insurance Australia Group’s proposed acquisition of RACQ Insurance, finding that competition in Queensland’s motor and home contents insurance markets remains robust despite the deal.